FDA Regulatory Tuesday, June 16, 2026 +0.85 Positive

FDA Approves Rextovy, Another OTC Naloxone Nasal Spray for Opioid Overdose

The FDA approved Rextovy, a 4mg naloxone hydrochloride nasal spray available over-the-counter for emergency opioid overdose treatment. This approval expands patient access to naloxone products without requiring a prescription.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day